Larry is a Special Limited Partner and currently serves as Chairman of Lux Ventures' Advisory Board of industry experts advising the Investment Team.
Larry was a co-founder and executive chairman of Nanosys, Inc. Prior to Nanosys, he was a managing general partner of CW Group, a life sciences venture capital fund. Larry was also a general partner of Avalon Ventures, a seed stage venture capital firm.
Larry has been the founder and initial chief executive officer of Metra Biosystems, Inc., Neurocrine Biosciences, Inc. (NASDAQ: NBIX - neuroimmunology), Pharmacopeia, Inc. (NASDAQ: PCOP - combinatorial chemistry), Argonaut Technologies, Inc (NASDAQ: AGNT - combinatorial chemistry), and Caliper Technologies Corp (NASDAQ: CALP - lab-on-a-chip).
Mr. Bock was also a co-founder of ARIAD Pharmaceuticals, Inc (NASDAQ: ARIA - intra cellular signal transduction), Athena Neurosciences (NASDAQ: ATHN, acquired by Elan Pharmaceuticals for $700M - molecular neurobiology) Inc., GenPharm International (acquired by MedaRx - transgenic animals), Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX - rational drug design), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX - molecular oncology) and Illumina, Inc. (NASDAQ: ILMN - array-based optical sensors).
Special Limited Partner
Board & Advisor Roles (6)Update
|Feb 5, 2016||Xconomy - West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More|
|Feb 4, 2016||PE HUB - Aira.IO grabs over $2.5 mln|
|Feb 4, 2016||San Diego Business Journal - Tech Company Aira.IO Raises $2.5 Million in Series A Financing|
|Feb 4, 2016||StrictlyVC - StrictlyVC: February 4, 2016|
|Feb 4, 2016||SoCal - Tech - Aira.IO Finds $2.5M To Assist The Blind|
|Oct 29, 2015||Med City News - Google Glass enabled navigation tool for visually disabled users gets seed funding|
|Oct 29, 2015||FinSMEs - Aira.IO Closes $790K Seed Financing|
|Jun 26, 2015||Xconomy - West Coast Biotech Roundup: Bock, Celladon, Arivale, Conkwest & More|